Back
CQTOA
Conneqt Health Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-55.67%
Annual Growth
2 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Conneqt Health Limited - Option Expiring 30-Nov-2025
📈 Performance
Price History
-90.00%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.00
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CQTOA
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in CQTOA
N/A
CQTOA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in CQTOA also invest in...
Want more shares? Try these...
Constellation Resources Ltd. engages in the development, construction, and mining activities. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-07-30. The firm manages the Orpheus Project comprising five tenements covering approximately 340 square kilometers in the Fraser Range province of Western Australia. In the Fraser Range, certain Proterozoic mafic/ ultramafic intrusion suites are prospective to host nickel-copper sulfide mineralization. The region's focus for exploration activities is nickel following the Nova, Silver Knight, Mawson, and Lantern discoveries. The Orpheus Project includes a 70% interest in two mineral exploration licenses (E28/2403 and E63/1281) and one mineral exploration license application (E63/1695). Additionally, the Company has 100% interests in two exploration licenses (E28/2738 and E28/2957).
🙌 Performance (5Yr p.a)
-11.80%
📊 Share price
$0.13 AUD
⛏️ MINING
CardieX Ltd. engages in the provision of designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. The company specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.
🙌 Performance (5Yr p.a)
-7.20%
📊 Share price
$0.03 AUD
🩺 HEALTH CARE